The Extrapolation Performance of Survival Models for Data With a Cure Fraction: A Simulation Study

被引:12
作者
Kearns, Benjamin [1 ]
Stevenson, Matt D. [1 ]
Triantafyllopoulos, Kostas [1 ]
Manca, Andrea [2 ]
机构
[1] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
[2] Univ York, Ctr Hlth Econ, York, N Yorkshire, England
基金
美国国家卫生研究院;
关键词
cure models; flexible survival models; forecasting; survival extrapolation; ECONOMIC EVALUATIONS;
D O I
10.1016/j.jval.2021.05.009
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Curative treatments can result in complex hazard functions. The use of standard survival models may result in poor extrapolations. Several models for data which may have a cure fraction are available, but comparisons of their extrapolation performance are lacking. A simulation study was performed to assess the performance of models with and without a cure fraction when fit to data with a cure fraction. Methods: Data were simulated from a Weibull cure model, with 9 scenarios corresponding to different lengths of follow-up and sample sizes. Cure and noncure versions of standard parametric, Royston-Parmar, and dynamic survival models were considered along with noncure fractional polynomial and generalized additive models. The mean-squared error and bias in estimates of the hazard function were estimated. Results: With the shortest follow-up, none of the cure models provided good extrapolations. Performance improved with increasing follow-up, except for the misspecified standard parametric cure model (lognormal). The performance of the flexible cure models was similar to that of the correctly specified cure model. Accurate estimates of the cured fraction were not necessary for accurate hazard estimates. Models without a cure fraction provided markedly worse extrapolations. Conclusions: For curative treatments, failure to model the cured fraction can lead to very poor extrapolations. Cure models provide improved extrapolations, but with immature data there may be insufficient evidence to choose between cure and noncure models, emphasizing the importance of clinical knowledge for model choice. Dynamic cure fraction models were robust to model misspecification, but standard parametric cure models were not.
引用
收藏
页码:1634 / 1642
页数:9
相关论文
共 18 条
[1]  
[Anonymous], TIS TREAT REL REFR B
[2]  
[Anonymous], NATL LIFE TABLES UK
[3]   A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for Improvement [J].
Bell Gorrod, Helen ;
Kearns, Ben ;
Stevens, John ;
Thokala, Praveen ;
Labeit, Alexander ;
Latimer, Nicholas ;
Tyas, David ;
Sowdani, Ahmed .
MEDICAL DECISION MAKING, 2019, 39 (08) :899-909
[4]   Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection [J].
Bullement, Ash ;
Willis, Anna ;
Amin, Amerah ;
Schlichting, Michael ;
Hatswell, Anthony James ;
Bharmal, Murtuza .
BMC MEDICAL RESEARCH METHODOLOGY, 2020, 20 (01)
[5]   A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available? [J].
Bullement, Ash ;
Meng, Yang ;
Cooper, Miranda ;
Lee, Dawn ;
Harding, Tara Louise ;
O'Regan, Chris ;
Aguiar-Ibanez, Raquel .
JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (03) :205-214
[6]   How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017 [J].
Gallacher, Daniel ;
Auguste, Peter ;
Connock, Martin .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (02) :160-167
[7]   Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation [J].
Gibson, Eddie ;
Koblbauer, Ian ;
Begum, Najida ;
Dranitsaris, George ;
Liew, Danny ;
McEwan, Phil ;
Monfared, Amir Abbas Tahami ;
Yuan, Yong ;
Juarez-Garcia, Ariadna ;
Tyas, David ;
Lees, Michael .
PHARMACOECONOMICS, 2017, 35 (12) :1257-1270
[8]   A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity [J].
Grant, Tim S. ;
Burns, Darren ;
Kiff, Christopher ;
Lee, Dawn .
PHARMACOECONOMICS, 2020, 38 (04) :385-395
[9]   flexsurv: A Platform for Parametric Survival Modeling in R [J].
Jackson, Christopher H. .
JOURNAL OF STATISTICAL SOFTWARE, 2016, 70 (08) :1-33
[10]   Estimating the loss of lifetime function using flexible parametric relative survival models [J].
Jakobsen, Lasse H. ;
Andersson, Therese M. -L. ;
Biccler, Jorne L. ;
El-Galaly, Tarec C. ;
Bogsted, Martin .
BMC MEDICAL RESEARCH METHODOLOGY, 2019, 19 (1)